EX-23.1 5 fusn-ex231_7.htm EX-23.1 fusn-ex231_7.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-239568 and 333-254687) and Form S-3 (No. 333-257653) of Fusion Pharmaceuticals Inc. of our report dated March 17, 2022 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 17, 2022